Back to All

Diaceutics PLC (AIM: DXRX), the diagnostic commercialisation company, announces it will be exhibiting at the Growth Innovation Forum 2020

6 February, 2020

Diaceutics PLC (AIM: DXRX), the diagnostic commercialisation company, announces it will be exhibiting at the Growth & Innovation Forum 2020 on Tuesday 11 February at the Business Design Centre, London.

Members of the Diaceutics management team will be at stand 23 throughout the day and Peter Keeling, CEO, will be presenting at 11.45am in the Babbage Room.

This is a one-day investor event where the exhibiting companies are focused on growth and technology. The show attracts both institutional and retail investors. For further information, please visit the event website at: https://www.sharesmagazine.co.uk/events/event/growth-innovation-forum-2020-1

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.